Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01519310 · ClinicalTrials.gov registry record · Early Phase 1

Gut Flora Dependent Metabolism of Dietary Phosphatidylcholine and Cardiovascular Disease

A Early Phase 1 study of Nutrition, sponsored by The Cleveland Clinic.

Completed
Registry status
Early Phase 1
Development phase
4
Enrollment target
1
Study location

NCT01519310 is a Early Phase 1 study of Nutrition that has completed, run by The Cleveland Clinic. The registered enrollment target is 4 participants, below the 3,209-participant average among 22 other Nutrition trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01519310, a Early Phase 1 study of Nutrition, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
Early Phase 1
Development phase
4 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to see if intestinal bacteria plays a role in choline metabolism (a form of choline monitored in this study is called phosphatidylcholine, also known as lecithin). This study will help to determine if choline metabolism is affected by short-term antibiotic therapy, and/or can be altered by probiotic therapy (e.g. in the form of eating yogurt).

Conditions Studied

Interventions

  • OTHER Antibiotic (metronidazole and ciprofloxacin)/probiotic

Study Locations (1)

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2010-04
Est. Completion 2014-10
Phase Early Phase 1

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT01519310

The ClinicalTrials.gov registry entry for NCT01519310 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,209-participant average among 22 other Nutrition trials with a reported enrollment target (100% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Nutrition appearing as the primary indexed condition, and to 1 intervention - of which Antibiotic (metronidazole and ciprofloxacin)/probiotic is the first listed.

NCT01519310 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT01519310 about?

NCT01519310 is a clinical study titled "Gut Flora Dependent Metabolism of Dietary Phosphatidylcholine and Cardiovascular Disease". The purpose of this study is to see if intestinal bacteria plays a role in choline metabolism (a form of choline monitored in this study is called phosphatidylcholine, also known as lecithin). This study will help to determine if choline metabolism is affected by short-term antibiotic therapy, and/o...

What is the current status of trial NCT01519310?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 4 participants. The study started on 2010-04. Estimated completion is 2014-10.

What conditions does trial NCT01519310 study?

This clinical trial studies the following conditions: Nutrition.

What interventions are being tested in trial NCT01519310?

The interventions under investigation include: Antibiotic (metronidazole and ciprofloxacin)/probiotic (OTHER).

Who is sponsoring clinical trial NCT01519310?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01519310 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Nutrition

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.